Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Specialization of Austria’s top companies in demand

illustration: China © pixabay

The high level of specialization on the part of Austria’s top companies is an important factor in M&A activities from Asia.

In 2017, five transactions were implemented by Chinese companies in Austria. Tele2 was acquired by the telecommunications group Hutchison Drei. The conglomerate HNA Group became the majority owner of the Vienna fund company C-Quadrat. The Chinese Haier Group purchased a stake in the Carinthian solar firm GREENoneTEC. The aviation producer Diamond Aircraft based in Wiener Neustadt became part of the Chinese Wanfeng Aviation Industry Corporation, and PIA Automation Holding owned by Ningbo Joyson Electronic took control of the Styrian automation specialist M&R Automation.

Read more:

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company
One of Austria's key strengths as a business destination is its highly qualified and motivated skilled workforce for research and development, especially in the scientific sector.

Nestlé Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts